BOT 2.47% 39.5¢ botanix pharmaceuticals ltd

The way I see it is we're back where we were in March after the...

  1. 215 Posts.
    lightbulb Created with Sketch. 35
    The way I see it is we're back where we were in March after the mid cycle review was positive and all that was needed was to tick the boxes on manufacturing and packaging except now we don't need to worry about manufacturing as they didn't flag any issues with that .
    To my mind we have only gone from 90% derisked to
    95%. But now we have 9 months to wait for approval and probably 12 months till product is on the market .
    For those reasons I can't see share price recovering until May/ June next year .
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
-0.010(2.47%)
Mkt cap ! $702.9M
Open High Low Value Volume
40.0¢ 40.0¢ 38.5¢ $1.231M 3.147M

Buyers (Bids)

No. Vol. Price($)
12 171744 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 816414 9
View Market Depth
Last trade - 11.12am 18/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.